🇺🇸 FDA
Company

REVIVA

REVIVA PHARMACEUTICALS HOLDINGS, INC.

RVPH pharma USA

Quick answer

REVIVA is a pharma company (RVPH) headquartered in CUPERTINO, CA, USA with 3 tracked pipeline programs.

Pipeline (3)

project

Brilaroxazine

Schizophrenia

Phase 3 · small_molecule · active

1 trials project

RP5063

Acute Schizophrenia

Phase 2 · small_molecule · completed

1 trials project

Lipoaspiration

Hereditary Corneal Dystrophy

Phase 1 · other · active

1 trials

Patents (8)

patent

US 12053477

Methods for treating pulmonary fibrosis

Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10441590

Methods for treating pulmonary hypertension

Expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10035761

Compositions, synthesis, and methods of using phenylcycloalkylmethylamine deriva

Expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9975862

Arylpiperazine derivatives and methods of utilizing same

Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9907803

Methods for treating attention deficit hyperactivity disorder

Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9695116

Compositions, synthesis, and methods of using phenylcycloalkylmethylamine deriva

Expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9604944

Arylpiperazine derivatives and methods of utilizing same

Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9302981

Synthesis, methods of using, and compositions of cycloalkylmethylamines

Expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)